Thirty adult patients with severe hemophilia A who received low-(n=20)/intermediate-dose(n=10)FVIII prophylaxis at Nanjing Drum Tower Hospital affiliated with Nanjing University Medical College were included in the study. Here, F8 is linked to hemophilia A.